Long-Term Observation of SARS-CoV-2 Vaccination Response upon High Efficacy Treatment in Multiple Sclerosis—A Real-World Scenario

Immunomodulatory and immunosuppressive therapy is needed in people with a chronic neuroinflammatory disease of the central nervous system such as multiple sclerosis (MS). Therefore, MS requires monitoring for and preventing against infectious diseases like SARS-CoV-2. Vaccination and anti-viral trea...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Muriel Schraad, Stefan Runkel, Walter Hitzler, Maria Protopapa, Stefan Bittner, Timo Uphaus, Frauke Zipp
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2024-03-01
סדרה:	Vaccines
נושאים:	SARS-CoV-2 vaccination multiple sclerosis efficiency booster vaccination sphingosine-1-phopshate receptor modulator
גישה מקוונת:	https://www.mdpi.com/2076-393X/12/3/296
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!